Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Tumour marker increased
ADR ID BADD_A07852
ADR Hierarchy
13      Investigations
13.22      Cytogenetic investigations
13.22.01      Cell marker analyses
13.22.01.017      Tumour marker increased
Description Not Available
MedDRA Code 10048621
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Tumour marker increased | Tumor marker increased
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000533%
BADD_D00142Anastrozole0.001131%
BADD_D00151Apixaban--
BADD_D00349Capecitabine0.001332%
BADD_D00367Carfilzomib0.000799%
BADD_D00858Everolimus0.007298%
BADD_D00861Exemestane0.009585%
BADD_D00912Fluconazole0.000412%
BADD_D00978Fulvestrant0.005884%
BADD_D01008Gefitinib0.000533%
BADD_D01136Imatinib0.000533%
BADD_D01223Ixazomib0.001332%
BADD_D01253Lenalidomide--
BADD_D01257Letrozole0.006152%
BADD_D01418Methotrexate--
BADD_D01567Nilotinib0.001066%
BADD_D01601Olaparib0.001865%
BADD_D01629Osimertinib0.000533%
BADD_D01654Palbociclib0.020514%
BADD_D01922Regorafenib0.007460%
BADD_D01954Rivaroxaban--
BADD_D01971Rosuvastatin0.000088%
BADD_D02058Sorafenib0.003197%
BADD_D02236Tofacitinib--
BADD_D02412Octreotide0.003921%
BADD_D02483Ribociclib0.002131%
BADD_D02486Niraparib0.002398%
BADD_D02498Abemaciclib0.001865%
BADD_D02510Rucaparib0.023178%
The 1th Page    1    Total 1 Pages